Epimedoside A

CAS No. 39012-04-9

Epimedoside A( —— )

Catalog No. M24352 CAS No. 39012-04-9

Epimedoside A has significant antioxidant activity in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 264 In Stock
5MG 187 In Stock
10MG 297 In Stock
25MG 502 In Stock
50MG 699 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Epimedoside A
  • Note
    Research use only, not for human use.
  • Brief Description
    Epimedoside A has significant antioxidant activity in vitro.
  • Description
    Epimedoside A has significant antioxidant activity in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    39012-04-9
  • Formula Weight
    662.7
  • Molecular Formula
    C32H38O15
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?Methanol : 6.25 mg/mL (9.43 m)
  • SMILES
    C/C(C)=C\CC1=C2C(C(C(O[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)=C(C4=CC=C(O)C=C4)O2)=O)=C(O)C=C1O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chemical constituents of roots of Epimedium wushanense and evaluation of their biological activities.Nat Prod Res. 2007 Jun;21(7):600-5.
molnova catalog
related products
  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • Lithium acetoacetate

    Acetoacetic acid (AcAc) is a weak organic acid that can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis).

  • Digitoxin

    Digitoxin is an effective Na+/K+-ATPase inhibitor, the EC50 value of Digitoxin is 0.78μM.